Let's get started

Make an Appointment
Find a Location
Find a Doctor
World-class experts. Close to you.

Many treatments and services are available at locations across NY and NJ.

Get care from the comfort of your home with telemedicine from MSK.

Explore MSK’s clinical trials

Our doctors and scientists work together so patients get access to cutting-edge treatments as soon as they are available.

Find a trial

Cancer news & discoveries
Eli L. Diamond, MD (left) and Omar Abdel-Wahab, MD (right).
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSK) announced that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic®) for the treatment of adult patients with the family of blood diseases known as histiocytic neoplasms (HN).
Read more
MSK President and CEO, Selwyn M. Vickers
Achieving Excellent Healthcare for All: A Candid Conversation with MSK’s New President & CEO, Dr. Selwyn Vickers
Dr. Selwyn Vickers was named President and CEO of Memorial Sloan Kettering Cancer Center in September 2022. His vision of a future with equal access and better outcomes for all has inspired the faculty and staff at MSK.
Listen now
Usmani Saad
FDA Approves Teclistamab, a Promising New Drug for Multiple Myeloma Targeting BCMA and CD3 Proteins
Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.
Read more